Investigation Overview
San Diego, Dec. 13, 2011 (Shareholders Foundation) -- The announcement that Synovis Life Technologies. agreed to be acquired by Baxter International for $28 per share prompted an investigation for investors in shares of Synovis Life Technologies, Inc. (NASDAQ:SYNO) concerning whether the offer to acquire Synovis Life Technologies and the buyout process are unfair to investors in NASDA...
You must register (for free) or login to view the entire investigation.